Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

Agnar Helgason*, Snæbjörn Pálsson, Gudmar Thorleifsson, Struan F.A. Grant, Valur Emilsson, Steinunn Gunnarsdottir, Adebowale Adeyemo, Yuanxiu Chen, Guanjie Chen, Inga Reynisdottir, Rafn Benediktsson, Anke Hinney, Torben Hansen, Gitte Andersen, Knut Borch-Johnsen, Torben Jorgensen, Helmut Schäfer, Mezbah Faruque, Ayo Doumatey, Jie ZhouRobert L. Wilensky, Muredach P. Reilly, Daniel J. Rader, Yu Bagger, Claus Christiansen, Gunnar Sigurdsson, Johannes Hebebrand, Oluf Pedersen, Unnur Thorsteinsdottir, Jeffrey R. Gulcher, Augustine Kong, Charles Rotimi, Kári Stefánsson

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstract

    We recently described an association between risk of type 2diabetes and variants in the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4), with a population attributable risk (PAR) of 17%-28% in three populations of European ancestry. Here, we refine the definition of the TCF7L2 type 2diabetes risk variant, HapBT2D, to the ancestral T allele of a SNP, rs7903146, through replication in West African and Danish type 2 diabetes case-control studies and an expanded Icelandic study. We also identify another variant of the same gene, HapA, that shows evidence of positive selection in East Asian, European and West African populations. Notably, HapA shows a suggestive association with body mass index and altered concentrations of the hunger-satiety hormones ghrelin and leptin in males, indicating that the selective advantage of HapA may have been mediated through effects on energy metabolism.

    OriginalsprogEngelsk
    Sider (fra-til)218-225
    Antal sider8
    TidsskriftNature Genetics
    Vol/bind39
    Udgave nummer2
    DOI
    StatusUdgivet - 1 feb. 2007

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution' indeholder.

    Citationsformater